Navigation Links
DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
Date:9/14/2008

with the Karolinska Institute in Stockholm, Sweden, a pilot clinical trial with the HER2 DNA vaccine has been conducted in patients with Stage IV breast cancer and has demonstrated safety. Further testing is being considered.

Dr. Wei added, "As we continue our extensive research on this promising vaccine, based on the results to-date, we believe this could eventually help control the spread of HER2-positive breast cancer in patients who have been resistant to other treatments, and possibly prevent HER2-positive breast cancer from occurring."

Other researchers working with Dr. Wei include: Paula J. Whittington, Marie P. Piechocki, Henry H. Heng, Jennifer B. Jacob, Richard F. Jones and Jessica B. Back.

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 41 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. John C. Ruckdeschel, M.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to http://www.karmanos.org.


'/>"/>
SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
6. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
7. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
8. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
9. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
10. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
11. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of Centers ... 2015 enrollment data shows that 81 percent of seniors ... and extra discounts at certain pharmacies. The findings were ... pharmacy plans are now the foundation of Medicare Part ...
(Date:1/23/2015)... Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) ... of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... its fiduciary duties to shareholders. On January ... website reporting that Advaxis had misrepresented the clinical data ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... 29 Zeltiq Aesthetics, a science-based medical device company dedicated ... unwanted fat tissue, has announced the appointment of Gordie ... Mitch Levinson, the founder of Zeltiq Aesthetics, who served as ... a member of the Board of Directors since 2006. ...
... Misonix, Inc. (Nasdaq: MSON ), a developer of ... is used for the ablation of tumors and worldwide ... release fourth quarter and fiscal year ended June 30, ... Michael A. McManus, President and Chief Executive Officer ...
Cached Medicine Technology:Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 3Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... a new blog post presenting a list of vehicles that cannot ... Some types of vehicles cannot be covered under an ordinary auto ... see if their vehicle qualifies for auto insurance coverage. , ... that cannot be covered by a plan. Clients have little options ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... a person loses a large amount of blood the consequences ... have to be kept available in hospitals and blood banks. ... villages and conducting blood donation sessions in a laboratory bus. ... taken contain pathogens, including HIV, hepatitis and syphilis. As these ...
... 1 , Watch4net,s Testimonial , ... healthcare providers in terms of limited personnel and budget ... Health. An industry typically marked by growth is starting ... level executives are being tasked to run leaner organizations ...
... Two-thirds of women with psoriasis say the disease ... PORTLAND, Ore., Oct. 1 Women with psoriasis and ... suffer from the emotional and psychological effects of the ... Psoriasis Foundation today. , Psoriasis is the most prevalent ...
... ... for life science careers and information, unveiled the eleventh edition of the Biotech Beach™ ... ... resource for life science careers and information, unveiled the eleventh edition of the Biotech ...
... ... University Edwardsville School of Pharmacy has launched a new Web site: www.pharmacypainsummit.com , ... pharmacy. , ... IL (PRWEB) October 1, 2009 -- The Southern Illinois University Edwardsville School of ...
... Oct.1 issue of the journal Sleep shows that ... consistently report that their sleep is shorter and poorer. ... all of the subjective measures, including a 13.2 minute shorter ... (SOL), and a 4.2 percent lower sleep efficiency. When sleep ...
Cached Medicine News:Health News:Blood diagnosis -- chip-based and mobile 2Health News:Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 2Health News:Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 2Health News:Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 3Health News:BioSpace Launches the 2010 Biotech Beach Hotbed Campaign 2Health News:SIUE School of Pharmacy Launches Collaborative Site for Pain, Palliative Care Pharmacy 2Health News:SIUE School of Pharmacy Launches Collaborative Site for Pain, Palliative Care Pharmacy 3Health News:Study shows that elderly women sleep better than they think, men sleep worse 2
... a fully threaded 2.4 mm diameter titanium suture ... predrilling using either a powered handpiece or manually ... This implant is ideal for Bankart and SLAP ... with very high pull-out strengths. FASTak anchors are ...
... one step fixation of soft tissue to bone. ... cuff repair in one simple insertion maneuver. The ... of 5 mm and a small 2 mm ... hold a thin, bioabsorbable PLLA disc 5 mm ...
... Needles are ideal for arthroscopic suture passing ... are preloaded on one end of each ... As the anchor is being inserted, ensure ... tissue before removing the handle to ensure ...
... a 3 mm x 14 mm bioabsorbable threaded ... shoulder, knee, elbow and ankle. The exclusive braided ... of the anchor and provides superior resistance to ... unique eyelet design allows the attached suture to ...
Medicine Products: